Welcome To Website IAS

Hot news
Achievement

Independence Award

- First Rank - Second Rank - Third Rank

Labour Award

- First Rank - Second Rank -Third Rank

National Award

 - Study on food stuff for animal(2005)

 - Study on rice breeding for export and domestic consumption(2005)

VIFOTEC Award

- Hybrid Maize by Single Cross V2002 (2003)

- Tomato Grafting to Manage Ralstonia Disease(2005)

- Cassava variety KM140(2010)

Centres
Website links
Vietnamese calendar
Library
Visitors summary
 Curently online :  37
 Total visitors :  7672540

Human Trials Begin for COVID-19 Plant-Based Technology Vaccine
Monday, 2020/07/27 | 08:19:27

 

Medicago announced that it has administered the first doses of its vaccine against COVID-19 to human volunteers. The results are expected to come out as early as October of this year.

 

The Quebec City-based company is able to develop a clinical-grade vaccine candidate in a matter of weeks using plant-based technology. They create their products with virus-like particles (VLP) instead of animal products or live viruses. The VLPs mimic the shape of the virus and allows the human body to recognize them, thus creating an immune response in a non-infectious way.

 

The Phase I Clinical Trials is a partially blinded study with 180 healthy participants. Three doses, 3.75, 7.5, and 15 micrograms, of the recombinant Corona Virus-Like Particle (CoVLP) vaccine candidate will be evaluated. The doses may be administered with the vaccine candidate alone, or with an adjuvant in a prime-boost regimen. An adjuvant is considered important during a pandemic because it boosts the immune response and reduces the amount of antigen required per dose. This allows the production of more vaccine doses thus maximizing the number of people that can be protected.

 

The Phase 2/3 Trial is also expected to initiate in October 2020.

 

Read Medicago's press release to learn more.

Back      Print      View: 206

[ Other News ]___________________________________________________
  • Egypt Holds Workshop on New Biotech Applications
  • UN Agencies Urge Transformation of Food Systems
  • Taiwan strongly supports management of brown planthopper—a major threat to rice production
  • IRRI Director General enjoins ASEAN states to invest in science for global food security
  • Rabies: Educate, vaccinate and eliminate
  • “As a wife I will help, manage, and love”: The value of qualitative research in understanding land tenure and gender in Ghana
  • CIP Director General Wells Reflects on CIP’s 45th Anniversary
  • Setting the record straight on oil palm and peat in SE Asia
  • Why insect pests love monocultures, and how plant diversity could change that
  • Researchers Modify Yeast to Show How Plants Respond to Auxin
  • GM Maize MIR162 Harvested in Large Scale Field Trial in Vinh Phuc, Vietnam
  • Conference Tackles Legal Obligations and Compensation on Biosafety Regulations in Vietnam
  • Iloilo Stakeholders Informed about New Biosafety Regulations in PH
  • Global wheat and rice harvests poised to set new record
  • GM Maize Harvested in Vietnam Field Trial Sites
  • New label for mountain products puts premium on biological and cultural diversity
  • The Nobel Prize in Physiology or Medicine 2016
  • Shalabh Dixit: The link between rice genes and rice farmers
  • People need affordable food, but prices must provide decent livelihoods for small-scale family farmers
  • GM Seeds Market Growth to Increase through 2020 Due to Rise in Biofuels Use

 

Designed & Powered by WEBSO CO.,LTD